| Biotechnology Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | - Employees | 30 Mar 2026 Last Dividend | - Last Split | - IPO Date |
BioNote, Inc. is a prominent player in the in-vitro diagnostic industry for animals, based in South Korea. Since its establishment in 2003, the company has dedicated itself to developing and marketing a wide range of diagnostic solutions aimed at improving animal health care. Through its innovative research and development efforts, BioNote, Inc. has expanded its product portfolio to cater to both veterinary and human diagnostic needs, thereby reinforcing its position within the diagnostics sector. The company is headquartered in Hwaseong-si, South Korea, standing as a testament to its commitment to contributing significantly to the biotechnology and diagnostic field.
BioNote, Inc.'s product line is extensive, covering various diagnostic methods and tools designed for accuracy, speed, and reliability. The main categories of their products include: